Furthermore, especially regarding the field of IBD, the investigation of lactoferrin effectiveness is still at the beginning, with several promising preliminary results that could represent the starting point for the development of well-structured clinical trials aimed to shed light on the therapeutic and/or supportive role of lactoferrin supplementation in the clinical management of this disease. Here, LTF is linked to irritable bowel syndrome.